Formerly known as BioSign, the Visensia technology evaluates up to five vital signs heart rate, respiration rate, body temperature, oxygen saturation and blood pressure and fuses this data into a single measurable index, the Visensia Index.
Enabled by the Food and Drug Administration (FDA) 510(k) clearance, the new Visensia system can allow hospital clinical staff to evaluate patient deterioration from central locations (department central station or hospital-wide patient safety response center). In addition, the new system will be able to integrate vital signs from periodic monitoring environments (such as medical/surgical floors and telemetry floors) to create the first-ever hospital-wide patient deterioration early warning system.
